Delivery Order SPE2DB20D3101-SPE2DB25FRUJ2
- Not listed
- The Defense Logistics Agency awarded a $1,352.49 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Simbrinza 1%-0.2% eye drops in an 8mL formulation. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.12 to AmerisourceBergen Drug Corp for Simbrinza 1%-0.2% eye drops (8mL) on June 6, 2025, with an ultimate completion date of June 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $2,585.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Simbrinza 1%-0.2% eye drops (8ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,275.50 firm fixed-price delivery order is for the supply of Simbrinza 1%-0.2% eye drops (8 mL) and has an ultimate completion date of November 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,117.10, is for the procurement of Simbrinza 1%-0.2% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of April 19, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,053.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of SIMBRINZA 1%-0.2% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SIMBRINZA 1%-0.2% eye drops in 8 mL containers. The fixed-price delivery order was awarded on October 9, 2024 with a ceiling value of $1,316.80 and a completion date of October 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,397.24 Firm Fixed Price delivery order contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a period of performance through March 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUJ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Simbrinza 1%-0.2% ophthalmic drops in an 8ml container. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with a completion deadline of September 4, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems worldwide. This delivery order for Simbrinza, a prescription eye drop medication used to treat elevated intraocular pressure in glaucoma and ocular hypertension patients, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems. The non-set-aside award reflects AmerisourceBergen's demonstrated capability to compete successfully for federal medical supply contracts while maintaining flexible pricing and delivery capabilities through its prime vendor agreement with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |